EIF3L Antikörper (C-Term)
Kurzübersicht für EIF3L Antikörper (C-Term) (ABIN4889129)
Target
Alle EIF3L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with human eIF3l protein
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide derived from C terminal part of human eIF3l protein
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only :
- IP : 1/250 - WB: 1/1000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- EIF3L (Eukaryotic Translation Initiation Factor 3, Subunit L (EIF3L))
-
Andere Bezeichnung
- Eukaryotic Translation Initiation Factor 3 Subunit L (eIF3l)
-
Hintergrund
- Belongs to the eIF-3 subunit L family. Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis.
-
UniProt
- Q9Y262
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Target
-